Apexigen, Inc. Deferred Tax Assets, in Process Research and Development

Apexigen, Inc. Deferred Tax Assets, in Process Research and Development

Apexigen, Inc. had Deferred Tax Assets, in Process Research and Development of $4.27 million as of 2022-12-31, per its 10-K filed 2023-02-22.

Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross

us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment · last filed 2023-02-22

• 2022-12-31: Deferred Tax Assets, in Process Research and Development $4.27M.
• 2021-12-31: Deferred Tax Assets, in Process Research and Development $0.00.